Profilassi Delle Complicazioni Trombo-Emboliche Nella Chirurgia Della Prostata Con L'Associazione Trasylol® Ed Eparina

1 Agus G. B. , Trezzi M. , Zanetta M. : Prevenzione e trattamento dell'edema da rivascolarizzazione arteriosa. Minerva chir., 30; 139 (1975).

2 Aiazzi Mancini M. , Donatelli L. : Trattato di farmacologia, p. 2343 (1970).

3 Amris C. J. , Hilden M. : Anticoagulant effects of Trasysol in vitro and in vivo studies. Ann. New York Acad. Sci., 146; 612 (1968).

4 Andersson L. : Fibrinolysis in patients with prostatic cancer. Acta Chir. Scad., 127; 552 (1964).

5 Battenti F. : Prevenzione e trattamento farmacologico delle emorragie fibrinolitiche conseguenti ad interventi sulla prostata. Urologia, 34; 158 (1967).

6 Benzer H. , Blümel G. , Piza F. : Experimentelle Untersuchungen zur Thrombose und Blutung bei Prostatektomien mit gleichzeitigem Beitrag zur Pathogenese der Thromboembolie. Wien. Klin. Wschr., 74; 601 (1962).

7 Blümel G. , Tölle W. , Lohninger A. : Studies on the free fatty acid composition of the lung tissue in the rabbit following experimental fractures. New aspects of Trasylol therapy, 6; 141 (1973).

8 Brooks M. R. : Heparin in the treatment of hemorragic diathesis associated with prostatic carcinoma. J. Urol., 102; 240 (1969).

9 Carbone C. , Di Grazia G. : L'impiego di farmaci antifibrinolitici (acido aminocaproico - Trasylol) in chirurgia prostatica. Arch. it. Urol., 33; 409 (1960).

10 Clowes G. H. A. , MacNicol M. , Voss H. , Altuc K. , Saravis C. : Inhibition by Trasylol of the production of plasma factors which cause pneumonitis and metabolic disorders in severe sepsis. New aspects of Trasylol therapy, 5; 209 (1972).

11 Costantini A. , Doni A. : Manifestazion. trombo-emorragiche di interesse urologico. Relaz. Congresso S.I.U., Venezia 1971.

12 Dubber A. H. C. , Macnicol G. P. , Uttley D. , Douglas A. : In vitro and in vivo studies with Trasylol, an anticoagulant and a fibrinolytic inhitor. Brit. J. Haemat., 14; 31 (1968).

13 Fürstenberg H. S. : Proteinase inhibitors in urology. Acta Chir. Scand., suppl. 378; 62 (1966).

14 Gordon-Smith I. C. , Grundy D. J. , Le Quesne L. , Newcombe F. , Bramble F. : Controlled trial of two regimens of subcutaneous heparin in prevention of postoperative deep-vein thrombosis. Lancet, 1; 1133 (1972).

15 Guarnieri G. , Rossi V. : L'impiego di un inibitore delle proteinasi nella chirurgia della prostata. Boll. Soc. med.-chir. Cremona, 3; 3 (1970).

16 Gjœnnaes H. : Cold promoted activation of factors VII. Thrombos. Diathes. Haemorrh. (Stuttgart), 28; 169 (1972).

17 Haberland G. , Koslowski L. , Matis P. : Il Trasylol nella terapia dello shock. Med. Welt, 23; 31 (1972).

18 Heideman M. , Bergentz S. , Lewis D. , Ljungqvist U. : The effect of Trasylol on the platelet reaction after trauma. New aspects of Trasylol therapy, 5; 195 (1972).

19 Heideman M. , Lewis D. : The effect of kallikrein on cell trapping in the lung. New aspects of Trasylol therapy, 6; 63 (1973).

20 Herschlein H. , Steichele D. : L'inibizione della ipercoagulabilità del sangue. Med. Welt, 24; 1314 (1964).

21 Kakkar V. , Corrigan T. , Spindler J. : Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. Lancet, 2; 101 (1972).

22 Konold P. : Inaugural Diss. Tübingen, 1965.

23 Kowalski E. : Fibrinogen derivatives and their biologic activities. Seminars Hemat., 5; 45 (1968).

24 Lasch H. G. , Heene D. , Huth K. , Sandritten W. : Pathophysiology, clinical manifestations and therapy of consumption-coagulopathy. Amer. J. Cardiol., 20; 381 (1967).

25 Matis P. , Konold P. , Mayer W. , Liebaldt G. : Thrombos. Diathes. Haemorrh., suppl. 15; 109 (1965).

26 Matis P. : Effects of Trasylol on blood clotting and wound healing. New aspects of Trasylol therapy, 2; 21 (1968).

27 Mc Kay D. G. : Pathology, diagnosis and therapy of disseminated intravascular coagulation. Proc. Roy. Soc. Med., 61; 1129 (1968).

28 Müller-Berghaus G. , Maul F. , Lasch H. : Prevention of the liquoid-induced consumption coagulopaty by the protease inhibitor aprotinin. Thromb. Diath. Haemorrh., 27; 396 (1972).

29 Nicolaides A. , Dupont A. , Desai S. , Lewis D. , Douglas N. , Dodsworth H. : Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet, 2; 890 (1972).

30 Nordström S. , Olsson P. , Blombäck M. : Ipercoagulabilità indotta dalla tromboplastina e sua prevenzione. Nature, 206; 632 (1965).

31 Phillips L. , Weiss R. , Wolf C. : Coagulation and fibrinolytic studies following use of proteinase inhibitors in prostatic surgery. Ann. N.Y. Acad. Sci., 146; 737 (1968).

32 Popov-Cenic S. , Egli H. : Generale Antikoagulation Prophylaxe in der Chirurgie. Med. Welt, 12; 2769 (1968).

33 Popov-Cenic S. : Reaktiv. Fibrinolyse und Proteinasen-inhibition. Neue Aspekte der Trasylol-therapie. Int. Symp., S. 173, Wiesbaden, 15-16 Nov. 1971.

34 Popov-Cenic S. : Medikamentose Thromboseprophylaxe. Med. Klin., 71; 1221 (1976).

35 Rasmessen J. , Albrechtsen O. , Astrup T. : Th. fibrinolytic activity in the human prostate and in seminal fluid. Trans. 6th Congr. Europ. Haematol, Copenahagen 1957.

36 Saito H. , Ratnoff O. D. : Inhibition of normal clotting and Flecter factor activity by rabbit anti-kallikrein antiserum. Nature, 248; 597 (1974).

37 Schnells G. : Inhibition of proteinases in shock treatment. Acta Anaesth., 25; 143 (1974).

38 Thibault Ph. : Thromboses post-operatoirés, Presse méd., 43; 2915 (1972).

39 Wanke M. , Schmidt J. , Höhn N. : Renal damage in post-pancreatitic shock and its therapeutic management. Experimental and clinical pathologic-anatomic findings. New aspects of Trasylol therapy, 5; F. K. Schattauer, Stuttgart 1972.

40 Wanke M. , Schumann G. : Quadro anatomo-patologico dello shock e delle due diverse forme. Trasylol, Nuovi orientamenti di terapia, 7. Estratto da « Chirurg », 45; 97 (1974).